Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
Subjective improvement in OSA symptoms was reported by all patients and objective PSG improvement was reported for 71% of those evaluated.
|
30639150 |
2019 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the traditional PSG-based OSA detection, people's sleep may be disturbed, meanwhile the electrode slices are easily to fall off.
|
31499731 |
2019 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
A total of 90 patients were enrolled into the study, 50 subjects were divided into OSA groups and 40 in healthy control according to PSG examination.
|
29843666 |
2018 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
Clinical and PSG factors were examined as predictors of OSA.
|
29880147 |
2018 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
A second PSG study performed 2 months postoperatively to confirm OSA resolution, and those with residual OSA were excluded.
|
30368376 |
2018 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
Surprisingly, RSWA values in PSG with melatonin were high, probably because of the still untreated OSAS.
|
28545360 |
2017 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
The review included observational studies in the English language with a clearly established aim to assess the relationship between OSAS and SB using full-night PSG.
|
27977045 |
2017 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
Sleep specialists should use the SBQ to conduct patient interviews for the early diagnosis of OSA in clinical settings, particularly in resource-poor countries and sleep clinics where PSG is unavailable.
|
27919588 |
2017 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
Within this population, L-PSG underestimates obstructive sleep apnea and central sleep apnea compared to H-PSG.
|
28934528 |
2017 |
Sleep Apnea, Obstructive
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The study group (PSG-confirmed OSAS) included 62 individuals, aged 51.7±10.3 years.
|
28501722 |
2017 |
Sleep Apnea, Obstructive
|
0.100 |
Biomarker
|
disease |
BEFREE |
Preoperative and postoperative (6 months) physical examination, PSG, bone age (BA) and osteocalcin (OC) evaluation were performed on the selected OSA children (n=92) and the healthy children (n=87).
|
27917446 |
2017 |